Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma Meeting Abstract

  

Authors:	Tan, C. R. C.; Rueda, C.; Shekarkhand, T.; Derkach, A.; Korde, N.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Lahoud, O. B.; Shah, G. L.; Scordo, M.; Chung, D. J.; Landau, H. J.; Giralt, S.; Usmani, S. Z.; Lesokhin, A. M.
Abstract Title:	Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma
Meeting Title:	2024 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	16 Suppl.
Meeting Dates:	2024 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-06-01
Language:	English
ACCESSION:	WOS:001275557401793
PROVIDER:	wos
DOI:	10.1200/JCO.2024.42.16_suppl.7570
Notes:	Meeting Abstract: 7570 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/218672